Browse > Article
http://dx.doi.org/10.5352/JLS.2011.21.11.1573

Silibinin Inhibits Cell Growth and Induces Apoptosis through Cell-cycle Arrest in PC-3 Prostate Cancer Cells  

Kim, Sang-Hun (Department of Microbiology and Immunology, Pusan National University School of Medicine)
Kim, Kwang-Youn (Department of Microbiology and Immunology, Pusan National University School of Medicine)
Yu, Sun-Nyoung (Department of Microbiology and Immunology, Pusan National University School of Medicine)
Jeon, Hyun-Joo (Department of Microbiology and Immunology, Pusan National University School of Medicine)
Jin, Young-Rang (Medical Research Institute, Pusan National University)
Lee, Chang-Min (Department of Internal Medicine, Yale University School of Medicine)
Ahn, Soon-Cheol (Department of Microbiology and Immunology, Pusan National University School of Medicine)
Publication Information
Journal of Life Science / v.21, no.11, 2011 , pp. 1573-1578 More about this Journal
Abstract
Milk thistle (silybum marianum) is a famous dietary supplement widely used in the United States and Europe. Silbinin is a major biologically active compound of milk thistle and has strong antioxidant and radical scavenger activities. Anticancer activities, as well as chemopreventive effects on various cancer cell lines, including prostate, lung, colon, skin, and bladder, have also been reported in silbinin. In the present study, we investigated the anticancer effects of silibinin and apoptosis through cell cycle arrest on prostate cancer cell PC-3. We performed cell viability by MTT assay and western blotting to confirm cell cycle check point proteins such as cyclin A/D1/E and cyclin-dependent kinase (CDK) 2/4/6. To quantify silibinin-induced apoptotic cell death of PC-3, Annexin V and PI double staining was performed by flow cytometry, by which its cell distribution was determined. As a result, silibinin inhibited the cell growth of PC-3 cells in a time- and dose-dependent manner, and its treatment resulted in cell cycle arrest at the G1 phase. Also the level of cell cycle check point proteins (cyclin, CDK) was decreased by silibinin in a dose-dependent manner. Taken together, we suggest that apoptosis of prostate cancer cell line PC-3 induced by silibinin is associated with cell cycle arrest through decrease of cell cycle check point proteins, caspase-3 activation and poly (ADP-ribose) polymerase (PARP) cleavage.
Keywords
Silibinin; apoptosis; cell cycle arrest; prostate cancer cells;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Raina, K., S. Rajamanickam, R. P. Singh, G. Deep, M. Chittezhath, and R. Agarwal. 2008. Stage specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in TRAMP Model. Cancer Res. 68, 6822-6830.   DOI   ScienceOn
2 Sharma, G., R. P. Singh, D. C. Chan, and R. Agarwal. 2003. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res. 23, 2649-2655.
3 Sherr, C. J. 2000. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 60, 3689-3695.
4 Singh, R. P., K. Raina, G. Deep, D. Chan, and R. Agarwal. 2009. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clin. Cancer Res. 15, 613-621.   DOI   ScienceOn
5 Tiwari, P., A. Kumar, S. Balakrishnan, H. S. Kushwaha, and K. P. Mishra. 2011. Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest. 1, 12-20.
6 Tyagi, A. K., C. Agarwal, R. P. Singh, K. R. Shroyer, L. M. Glode, and R. Agarwal. 2003. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem. Biophys. Res. Commun. 312, 1178-1184.   DOI   ScienceOn
7 Kong, E. H., Y. J. Kim, Y. J. Kim, H. J. Cho, S. N. Yu, K. Y. Kim, J. H. Chang, and S. C. Ahn. 2008. Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells. Oncol. Rep. 20, 785-792.
8 Liu, M. J., Z. Wang, Y. Ju, R. N. Wong, and Q. Y. Wu. 2004. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of $Ca^{2+}$ homeostasis. Cancer Chemother. Pharmacol. 55, 79-90.
9 Dhanalakshmi, S., R. P. Singh, C. Agarwal, and R. Agarwal. 2002. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis. Oncogene 21, 1759-1767.   DOI   ScienceOn
10 Eom, K. S., H. J. Kim, H. S. So, R. Park, and T. Y. Kim. 2010. Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol. Pharm. Bull. 33, 1644-1649.   DOI   ScienceOn
11 Flaig, T. W., L. J. Su, G. Harrison, R. Agarwal, and L. M. Glodé. 2007. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int. J. Cancer 120, 2028-2033.   DOI   ScienceOn
12 Jackson, S. J. and K. W. Singletary. 2004. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J. Nutr. 134, 2229-2236.
13 Jin, C. Y., G. Y. Kim, and Y. H. Choi. 2008. Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of akt in human breast cancer MDA-MB-231 cells. J. Microbiol. Biotechnol. 18, 1997-2003.
14 Kim, D. W., S. L. Kwang, M. K. Kim, Y. H. Cho, and C. H. Lee. 2001. Inhibitory mechanisms of cell cycle regulation induced by indole-3-carbinol in hepatocellular carcinoma HepG2 cells. Korean J. Appl. Microbiol. Biotechnol. 29, 181-185.
15 Prasad, S., J. Kaur, P. Roy, N. Kalra, and Y. Shukla. 2007. Theaflavins induce G2/M arrest by modulating expression of p21waf1/cip1, cdc25C and cyclin B in human prostate carcinoma PC-3 cells. Life Sci. 81, 1323-1331.   DOI   ScienceOn
16 Tyagi, A., C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal. 2004. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25, 1711-1720.   DOI
17 Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330.   DOI   ScienceOn
18 Yang, S. H., J. K. Lin, W. S. Chen, and J. H. Chiu. 2003. Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J. Surg. Res. 113, 133-138.   DOI   ScienceOn
19 Zhu, W., J. S. Zhang, and C. Y. Young. 2001. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis 22, 1399-1403.   DOI
20 Pham, N. A., J. W. Jacobberger, A. D. Schimmer, P. Cao, M. Gronda, and D. W. Hedley. 2004. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol. Cancer Ther. 3, 1239-1248.
21 Mokhtari, M. J., N. Motamed, and M. A. Shokrgozar. 2008. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line. Cell. Biol. Int. 32, 888-892.   DOI   ScienceOn
22 Li, L., Y. Gao, L. Zhang, J. Zeng, D. He, and Y. Sun. 2008. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Cancer Letters 272, 61-69.   DOI   ScienceOn
23 Mateen, S., A. Tyagi, C. Agarwal, R. P. Singh, and R. Agarwal. 2010. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cells arrest by modulating expression and function of key cell-cycle regulators. Mol. Carcinog. 49, 247-58.
24 Mohan, S., S. Dhanalakshmi, G. U. Mallikarjuna, R. P. Singh, and R. Agarwal. 2004. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 320, 183-189.   DOI   ScienceOn
25 Noh, E. M., M. S. Yi, H. J. Youn, B. K. Lee, Y. R. Lee, J. H. Han, H. N. Yu, J. S. Kim, and S. H. Jung. 2011. Silibinin enhances ultraviolet B-induced apoptosis in mcf-7 human breast cancer cells. J Breast Cancer 1, 8-13.
26 Parnaud, G., P. Li, G. Cassar, P. Rouimi, J. Tulliez, L. Combaret, and L. Gamet-Payrastre. 2004. Mechanism of sulforaphane- induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer 48, 198-206.   DOI   ScienceOn
27 Deep, G., N. H. Oberlies, D. J. Kroll, and R. Agarwal. 2008. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int. J. Cancer 123, 41-50.   DOI   ScienceOn
28 Dhanalakshmi, S., G. U. Mallikarjuna, R. P. Singh, and R. Agarwal. 2004. Dual efficacy of silibinin in protecting or enhancing ultraviolet B radiation-caused apoptosis in HaCaT human immortalized keratinocytes. Carcinogenesis 25, 99-106.   DOI
29 Agarwal, C., R. P. Singh, S. Dhanalakshmi, A. K. Tyagi, M. Tecklenburg, R. A. Sclafani, and R. Agarwal. 2003. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22, 8271-8282.   DOI   ScienceOn
30 Agarwal, C., A. Tyagi, M. Kaur, and R. Agarwal. 2007. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 7, 1463-1470.
31 Aktas, H., H. Cai, and G. M. Cooper. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell Biol. 17, 3850-3857.
32 Chen, P. N., Y. S. Hsieh, C. L. Chiang, H. L. Chiou, S. F. Yang, and S. C. Chu. 2006. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res. 85, 220-225.   DOI   ScienceOn
33 Chen, P. N., Y. S. Hsieh, H. L. Chiou, and S. C. Chu. 2005. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem. Biol. Interact. 156, 141-150.   DOI   ScienceOn
34 Chu, S. C., H. L. Chiou, P. N. Chen, S. F. Yang, and Y. S. Hsieh. 2004. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol. Carcinog. 40, 143-149.   DOI   ScienceOn